GWM
JAZZ icon

Gupta Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Gupta Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-409
Closed -$72K – 1301
2015
Q2 		$72K Hold
409
– – 0.02% 395
2015
Q1 		$71K Buy
+409
New +$70.2K 0.02% 348

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Gupta Wealth Management's JAZZ Position: Q3 2015 in Review

Gupta Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2015, closing a stake of 409 shares — an estimated $72K sold.

Gupta Wealth Management first reported a position in JAZZ in Q1 2015 and held it in 2 quarters. The position peaked at $72K in Q2 2015. 360 funds tracked by Wall St. Rank hold JAZZ as of Q3 2015.

  • Gupta Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Gupta Wealth Management sold 409 Jazz Pharmaceuticals shares in Q3 2015, an estimated $72K.
  • Gupta Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2015 and held it in 2 quarters.
  • Gupta Wealth Management's Jazz Pharmaceuticals position peaked at $72K in Q2 2015.
  • 360 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2015.

Based on Gupta Wealth Management's 13F filing for Q3 2015, filed 18 Nov 2015.